Medicann Logo
Weekly Update
6 March 2026

Medicinal Cannabis Matters: Friday Roundup - 6 March 2026

Each week, the conversation around medicinal cannabis continues to grow as new patient stories, research and policy discussions highlight how this treatment is changing lives. From individuals managing long-term conditions to campaigns pushing for greater awareness and access, the evidence and experiences emerging across the UK continue to shape the future of care. This week’s roundup explores a powerful patient story about living with multiple sclerosis, how medicinal cannabis has helped manage a chronic skin condition and a campaign honouring the legacy of Hannah Deacon, a dear friend of Medicann’s, who played a role in changing UK cannabis law.

5 min read
Medicinal Cannabis Matters: Friday Roundup - 6 March 2026

A patient with MS shares how medicinal cannabis changed daily life

A recent article from Yahoo News highlights the experience of a Cumbrian patient living with multiple sclerosis who says medicinal cannabis has dramatically improved his quality of life.

According to the report, the patient had previously struggled with severe muscle spasms, pain and limited mobility. After being prescribed medicinal cannabis through a specialist clinic, he described a significant reduction in symptoms, allowing him to regain greater independence and return to activities that had become difficult or impossible.

Stories like this continue to illustrate the potential role medicinal cannabis can play for people living with neurological conditions. For patients with multiple sclerosis, treatment may help manage symptoms such as muscle stiffness, pain and sleep disruption when conventional treatments have not provided sufficient relief.

Managing chronic eczema symptoms with medicinal cannabis

Another patient story this week comes from Cambridgeshire, where one man says medicinal cannabis has helped him manage severe eczema after years of struggling with the condition.

The patient had experienced persistent flare-ups and discomfort for many years. After exploring medicinal cannabis treatment, he found it helped reduce inflammation and irritation, improving his overall quality of life and making daily symptoms more manageable.

Chronic inflammatory conditions such as eczema can significantly affect sleep, comfort and mental wellbeing. While treatment approaches vary, medicinal cannabis is increasingly being explored for its potential anti-inflammatory and immunomodulatory effects.

Campaign launched in memory of Hannah Deacon who helped change UK law

A moving campaign has also been launched in memory of our dear friend, Hannah Deacon, who played a part in changing the conversation around medicinal cannabis in the UK.

The campaign honours her advocacy for patients seeking access to medicinal cannabis treatment, particularly for children with severe epilepsy. Her work contributed to raising awareness at a time when families across the country were fighting for legal access to treatments that could help manage life-threatening seizures.

Today, medicinal cannabis is legal in the UK when prescribed by specialist doctors, but the campaign highlights that awareness and access remain ongoing challenges. Patient advocacy continues to play a vital role in ensuring people understand their treatment options and can access safe, regulated care when appropriate.

Across the UK and Channel Islands, patient stories continue to demonstrate how medicinal cannabis can support people living with a wide range of conditions when prescribed responsibly by experienced clinicians.

As awareness grows, it remains important that patients access treatment through regulated medical pathways where care is guided by specialist doctors, supported by clinical evidence and delivered safely.

If you are living with a chronic condition and would like to explore whether medicinal cannabis may be an appropriate treatment option, you can check your eligibility online in just two minutes using our simple eligibility checker.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.

Share